golotimod: Clinical Trials

3 completed, 1 unknown. 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	3	Completed 2, Unknown 1

Follow golotimod: new trials by email Literature Review of golotimod trials Research Report on golotimod

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer SCV-07, Placebo - Oral Mucositis	Phase 2	Unknown	SciClone Pharmaceuticals	160	2010-12-01	2014-05-26
Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV SCV-07 - Chronic Hepatitis C		Completed	SciClone Pharmaceuticals	12	2010-08-01	2012-03-08
Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed SCV-07 - Chronic Hepatitis C	Phase 2	Completed	SciClone Pharmaceuticals	40	2009-09-01	2012-06-08
Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer Placebo, SCV-07 - Oral Mucositis, Head and Neck Cancer	Phase 2	Completed	SciClone Pharmaceuticals	59	2008-09-01	2009-11-23

Conditions studied

Head and Neck Neoplasms (2)  ·  Hepatitis C, Chronic (2)  ·  Stomatitis (2)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Hepatitis C (1)  ·  Mouth Diseases (1)  ·  Mucositis (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Stomatognathic Diseases (1)

Sponsors

SciClone Pharmaceuticals (4)

Countries

United States (4)

Top investigators

Israel Rios, MD (2)  ·  Katharina Modelska, MD (1)